HomePortfoliosTillväxt baby

Tillväxt baby

Optimize
Annual Rebalancing
EUR
High Risk
5.7yr backtest

Performance Summary

Total Return+402.10%
Annualized Return+32.76%
Volatility+28.46%
Sharpe Ratio1.08
Max Drawdown+33.75%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Invest in a 100% tech-focused equity portfolio with top semiconductor and U.S. information technology ETFs for targeted growth.
AssetTypeAllocationTER
VVSM.XETRA
VanEck Semiconductor UCITS ETFIE00BMC38736
ETF
70.0%0.35%
QDVE.XETRA
iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc)IE00B3WJKG14
ETF
30.0%0.15%
Total100.0%0.29%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €50,209.72
Histogram of Monthly Returns
The portfolio had a positive return during 43 of the 69 months (62%)
Monthly Returns Heatmap
Best month: +30.8% • Worst month: -15.8% • Best year: 2023 (+65.3%) • Worst year: 2022 (-30.7%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+9.7%-1.5%-6.6%+30.8%+22.8%+10.8%-15.8%+6.9%----+61.8%
2025+1.8%-7.0%-12.7%-4.3%+13.2%+10.0%+6.7%-2.2%+10.3%+13.6%-3.9%+2.0%+26.2%
2024+6.2%+9.7%+4.8%-3.3%+5.2%+12.0%-7.3%-3.0%+1.2%-0.3%+4.4%+3.2%+35.8%
2023+12.8%+3.7%+7.4%-6.2%+19.7%+3.0%+2.9%-1.2%-3.9%-3.8%+11.6%+8.5%+65.3%
2022-11.3%-1.2%+3.5%-8.2%-1.4%-11.8%+15.7%-6.1%-9.3%+1.8%+4.8%-8.9%-30.7%
2021+5.3%+3.7%+4.1%+0.2%-0.8%+8.8%+1.2%+4.5%-2.9%+5.6%+12.0%+3.7%+54.8%
2020-----------+2.0%+2.0%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +33.75% • The longest drawdown period lasted for 1 year and 4 months and was between January 2022 and May 2023. It reached a trough of -32.6%.

Detailed Metrics

Returns
Total Return
+402.10%
Annualized Return
+32.76%
Avg Monthly Return
+2.71%
Risk
Volatility (Annual)
+28.46%
Max Drawdown
+33.75%
Positive Months
62%
Average Drawdown
-9.8%
Risk-Adjusted
Sharpe Ratio
1.08
Risk-free rate: 2.0%
Sortino Ratio
1.06
Downside risk adjusted
Return/Volatility
1.15
Calmar Ratio
0.97
Return/Max Drawdown
Ulcer Index
12.20
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
50,209.72
Backtest Period
2020-12-03 to 2026-08-14
5.7 years
Rebalancing
annual
Base Currency
EUR